Cargando…

A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype

Increasing evidence suggests that ion channels not only regulate electric signaling in excitable cells but also play important roles in the development of brain tumor. However, the roles of ion channels in glioma remain controversial. In the present study, we systematically analyzed the expression p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hao-Yuan, Li, Ji-Ye, Liu, Xiu, Yan, Xiao-Yan, Wang, Wen, Wu, Fan, Liang, Ting-Yu, Yang, Fan, Hu, Hui-Min, Mao, Heng-Xu, Liu, Yan-Wei, Zhang, Shi-Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342710/ https://www.ncbi.nlm.nih.gov/pubmed/27713134 http://dx.doi.org/10.18632/oncotarget.12462

Ejemplares similares

A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma
por: Wang, Wen, et al.
Publicado: (2016)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

Molecular subtyping of glioblastoma based on immune-related genes for prognosis
por: Chen, Xueran, et al.
Publicado: (2020)

A Ferroptosis Molecular Subtype-Related Signature for Predicting Prognosis and Response to Chemotherapy in Patients with Chronic Lymphocytic Leukemia
por: Gong, Han, et al.
Publicado: (2022)

Ion Channels in Glioblastoma
por: Molenaar, Remco J.
Publicado: (2011)

Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
por: Liu, Da, et al.
Publicado: (2023)

An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma
por: Gong, Zhenyu, et al.
Publicado: (2020)

Development of an Aging-Related Gene Signature for Predicting Prognosis, Immunotherapy, and Chemotherapy Benefits in Rectal Cancer
por: Wang, Yangyang, et al.
Publicado: (2022)

Identification of pyroptosis-related lncRNA subtype and signature predicts the prognosis in bladder cancer
por: Zeng, Tao, et al.
Publicado: (2023)

Identification of an N6-methyladenosine (m6A)-related signature associated with clinical prognosis, immune response, and chemotherapy in primary glioblastomas
por: Cai, Zhiqiang, et al.
Publicado: (2021)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

A three‐microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes
por: Marziali, Giovanna, et al.
Publicado: (2017)

Gene pathways associated with prognosis and chemotherapy sensitivity in different molecular subtypes of breast cancer
por: Pusztai, L
Publicado: (2011)

Deep learning identified glioblastoma subtypes based on internal genomic expression ranks
por: Mao, Xing-gang, et al.
Publicado: (2022)

Role of alternative splicing signatures in the prognosis of glioblastoma
por: Xie, Zu‐cheng, et al.
Publicado: (2019)

Ion channels as molecular targets of glioblastoma electrotherapy
por: Abed, Tayeb, et al.
Publicado: (2023)

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma
por: Ji, Hang, et al.
Publicado: (2022)

Angiogenesis-Related Gene Signature-Derived Risk Score for Glioblastoma: Prospects for Predicting Prognosis and Immune Heterogeneity in Glioblastoma
por: Wang, Gang, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Necroptosis-related signatures identify two distinct hepatocellular carcinoma subtypes: Implications for predicting drug sensitivity and prognosis
por: Tang, Hui, et al.
Publicado: (2023)

Novel tumor necrosis factor-related long non-coding RNAs signature for risk stratification and prognosis in glioblastoma
por: Long, Shengrong, et al.
Publicado: (2023)

A novel twelve-gene signature to predict neoadjuvant chemotherapy response and prognosis in breast cancer
por: Wu, Jin, et al.
Publicado: (2022)

Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes
por: Wang, Hanyu, et al.
Publicado: (2022)

MicroRNA Signatures and Molecular Subtypes of Glioblastoma: The Role of Extracellular Transfer
por: Godlewski, Jakub, et al.
Publicado: (2017)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma
por: Zeng, Fa-Min, et al.
Publicado: (2019)

Cuproptosis-related signature predicts prognosis, immunotherapy efficacy, and chemotherapy sensitivity in lung adenocarcinoma
por: Wu, Gujie, et al.
Publicado: (2023)

The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma
por: Sforna, Luigi, et al.
Publicado: (2015)

Tumor Microenvironment Subtypes and Immune-Related Signatures for the Prognosis of Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2021)

A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
por: Wei, Nan, et al.
Publicado: (2022)

A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma
por: Liu, Chang, et al.
Publicado: (2022)

Identification of T‐cell exhaustion‐related gene signature for predicting prognosis in glioblastoma multiforme
por: Liu, Yue‐hui, et al.
Publicado: (2023)

CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells
por: Mao, Diane D., et al.
Publicado: (2022)

Identification of tumor-associated antigens and immune subtypes of lower-grade glioma and glioblastoma for mRNA vaccine development
por: Wang, Zhi-liang, et al.
Publicado: (2022)

MicroRNA profiling of Chinese primary glioblastoma reveals a temozolomide-chemoresistant subtype
por: Yan, Wei, et al.
Publicado: (2015)

31 gene expression-based signatures serve as indicators of prognosis for patients with glioma
por: Yan, Zhongjun, et al.
Publicado: (2019)

Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes
por: Kessler, Tobias, et al.
Publicado: (2020)

Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer
por: Zhang, Jun, et al.
Publicado: (2020)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Glioblastoma: two immune subtypes under the surface of the cold tumor
por: Xiong, Wu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0niicb4e04au83e5i5e7mllo5l